Walgreens Boots Alliance reports Q1 adjusted EPS $1.16, consensus $1.13

Reports Q1 revenue $33.38B, consensus $32.83B. The U.S. Retail Pharmacy segment had first quarter sales of $27.2B, a decrease of 3% from the year-ago quarter. Comparable sales increased 3.8% from the year-ago quarter while lapping strong comparable sales of 7.9 percent in the year-ago quarter. The year-ago quarter included a significant contribution from COVID-19 vaccinations. CEO Rosalind Brewer said: "WBA delivered a solid start to the fiscal year, as we continue to accelerate our transformation to a consumer-centric healthcare company. We’re making significant progress in driving our U.S. Healthcare segment to scale and profit, including the recent VillageMD acquisition of Summit Health. Our core retail pharmacy businesses in both the United States and United Kingdom remain resilient in challenging operating environments. Execution across segments reinforces our confidence in achieving full-year guidance, and our strategic actions are creating long-term shareholder value."